Hypobilirubinemia might be a possible risk factor of end-stage kidney disease independently of estimated glomerular filtration rate

Kidney and Blood Pressure Research

Volumn 36, Issue 1, 2012, Pages 47-54

  Oda, Eiji ^a   Aoyagi, Ryuzi ^a   Aizawa, Yoshifusa ^a  

^a Tachikawa Medical Center   (Japan)

Author keywords

Bilirubin; Chronic kidney disease; End Stage kidney disease; Estimated GFR

Indexed keywords

BILIRUBIN;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISORDERS OF PORPHYRIN AND HEME METABOLISM; FEMALE; GEOMETRY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERBILIRUBINEMIA; HYPOBILIRUBINEMIA; INCIDENCE; KIDNEY FAILURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; BILIRUBIN; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERBILIRUBINEMIA; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84864100272     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000339027     Document Type: Article

References (26)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States JAMA 2007;298: 2038-2047.
2. Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD: Association of single measurements of dipstick proteinuria, estimated glomerular iltration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 2006;17:1444-1452.
3. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of estimated glomerular iltration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-81.
4. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeoffer M, Raij L, Spinosa DJ, Wilson PW: American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-2169.
5. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-663.
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
7. Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyrén O, Fored CM: The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 2005;46:863-870.
8. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043-1046.
9. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG: Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995;41:1504-1508.
10. Troughton JA, Woodside JV, Young IS, Arveiler D, Amouyel P, Ferrières J, Ducimetière P, Patterson CC, Kee F, Yarnell JW, Evans A: PRIME Study Group: Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil 2007;14:79-84.
11. Oda E, Kawai R: A possible cross-sectional association of serum total bilirubin with coronary heart disease and stroke in a Japanese health screening population. Heart Vessels 2012;27:29-36.
12. Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, Hasegawa G, Nakamura N: Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int 2008;74:1197-1201.
13. Shin HS, Jung YS, Rim H: Relationship of serum bilirubin concentration to kidney function and 24-hour urine protein in Korean adults. BMC Nephrol 2011;12:29.
14. Targher G, Zoppini G, Guidi GC: Relationship between serum bilirubin and kidney function in non-diabetic and diabetic individuals. Kidney Int 2009;75:863.
15. Targher G, Bosworth C, Kendrick J, Smits G, Lippi G, Chonchol M: Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Clin Chem Lab Med 2009;47:1055-1062.
16. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-992.
17. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The de inition, classi ication, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80:17-28.
18. Erdogan D, Gullu H, Yildirim E, Tok D, Kirbas I, Ciftci O, Baycan ST, Muderrisoglu H: Low serum bilirubin levels are independently and inversely related to impaired low-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 2006;184:431-437.
19. Gullu H, Erdogan D, Tok D, Topcu S, Caliskan M, Ulus T, Muderrisoglu H: High serum bilirubin concentrations preserve coronary low reserve and coronary microvascular functions. Arterioscler Thromb Vasc Biol 2005;25:2289-2294.
20. Tanaka M, Fukui M, Tomiyasu K, Akabame S, Nakano K, Hasegawa G, Oda Y, Nakamura N: Low serum bilirubin concentration is associated with coronary artery calci ication (CAC). Atherosclerosis 2009;206:287-291.
21. Öllinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, Csizmadia E, Graça-Souza AV, Liloia A, Soares MP, Otterbein LE, Usheva A, Yamashita K, Bach FH: Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005;112:1030-1039.
22. Kao MPC, Ang DSC, Pall A, Struthers AD: Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options. J Hum Hypertens 2010;24:1-8.
23. Vera T, Stec DE: Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 2010;299:R1044-R1049.
24. Botros FT, Schwartzman ML, Stier CT Jr, Goodman AI, Abraham NG: Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 2005;68:2745-2755.
25. Nanayakkara PW, van Guldener C, ter Wee PM, Scheoffer PG, van Ittersum FJ, Twisk JW, Teerlink T, van Dorp W, Stehouwer CD: Eoffect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insuf iciency (ATIC) Study. Arch Intern Med 2007;167:1262-1270.
26. McCarty MF: "Iatrogenic Gilbert syndrome"-a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypotheses 2007;69:974-994.